Pharmaceutical company Sanofi-Aventis is eliminating “hundreds of jobs,” reports Ed Silverman at Pharmalot. The cuts come in the wake of Sanofi’s acquisition of Genzyme, he say, adding that some R&D operations will be shuffled between its New Jersey and Massachusetts sites, and that there will be layoffs in sales, particularly in the cardiovascular and oncology groups.